Somni bene Institut fuer medizinische Forschung und Schlafmedizin Schwerin GmbH — Clinical Trial Site

15 Registered trials

2 Currently recruiting

Organisation

Somni bene Institut fuer medizinische Forschung und Schlafmedizin Schwerin GmbH

Location

Schwerin, Germany

Identifier

ORG-100033245

Address

Goethestrasse 1, Feldstadt, 19053, Germany

Departments

-
Chronic pain
Institut fuer medizinische Forschung und Schlafmedizin Schwerin GmbH
Institut für Medizinische Forschung und Schlafmedizin
Institute for Medical Research and Sleep Medicine
N/A
NA
Neurologie/Schlafmedizin
Not applicable
SOMNIBENE Institut für Medizinische Forschung und Schlafmedizin Schwerin GmbH

Clinical trials at this site (15)

Search interface

A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Monotherapy Study of the Efficacy, Safety, and Tolerability of SPT-300 in Ad… Recruiting

2025-521240-37-00 Major Depressive Disorder (MDD), with or without Anxiou 4 2025-09-11
A 6-Week, Multicenter, Open-Label, Monotherapy, Extension Study of SPT-300 in Adults with Major Depressive Disorder, With or Without Anxious… Recruiting

2025-522347-18-00 Major Depressive Disorder (MDD), with or without Anxiou 4 2025-11-26
A Trial to Evaluate the Long-term Safety and Tolerability of TAK-861 Ended

2023-508462-15-00 Narcolepsy with Cataplexy (Narcolepsy Type 1) 10 2023-04-27
A multicenter, double-blind, randomized study to evaluate the effects of tasimelteon vs. placebo in participants with Delayed Sleep-Wake Pha… Ended

2024-516962-13-00 Delayed Sleep-Wake Phase Disorder (DSWPD) 5 2022-09-23
A 14-week, multicentre, double-blind, randomised, placebo-controlled phase II study with an 8-week treatment period to assess the efficacy a… Ended

2024-513104-34-00 Major Depressive Disorder 4 2024-11-25
RCT of Medical Cannabis Aerosol for DPNP Treatment Ended

2023-508932-68-00 Diabetic Peripheral Neuropathic Pain 4 2024-11-14
A Study to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy with Cataplexy Ended

2023-508465-32-00 Narcolepsy with Cataplexy (Narcolepsy Type 1) 5 2024-09-03
A study to test different doses of BI 1569912 in people with depression who take anti-depressive medicine Ended

2023-507942-10-00 Major depressive disorder 4 2024-07-31
A study to learn about how elinzanetant works and how safe it is in women having sleep disturbances associated with menopause Ended

2023-504955-28-01 Sleep disturbances associated with menopause 4 2024-03-14
Dose-response characterization of VER-01 in the treatment of patients with chronic non-specific low back pain Ended

2023-507358-34-00 For the treatment of patients with chronic non-specific 4 2024-02-13
UNITAS Ended

2022-502483-21-00 Insomnia disorder 4 2023-07-28
Protocol Lay Person Short Title: A Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment o… Ended

2022-500538-27-00 Adjunctive therapy to antidepressants for the treatmen 10 2023-03-30
A study to find out if daridorexant is safe and efficacious to treat insomnia in patients with insomnia and comorbid nocturia Ended

2022-501246-30-00 Insomnia Disorder 6 2023-03-08
A study to find out which dose of daridorexant is safe and effective to treat insomnia in children and adolescents 10 to <18 years old Ended

2024-513885-20-00 Insomnia Disorder 4 2022-12-05
CHRONDI Ended

2024-513595-17-00 CHRONIC PAIN DUE TO DIABETIC PERIPHERAL NEUROPATHY 4